Technical Stock Analysis. Gilead Sciences, Inc. (NASDAQ:GILD), a Healthcare sector firm, traded 7.99 Million shares in last trading session and stock edged up 0.75% with closing price of $67.44 per share. Company gross margins represents its total
Updated: 11/28/2018 07:31A
Big-cap biotech leaders Biogen Idec (NASDAQ:BIIB) and Gilead Sciences (NASDAQ:GILD) easily beat second-quarter earnings estimates and received product approvals Wednesday, but their stocks reacted very differently. Biogenearnings rose 52% vs. a ...
Updated: 07/23/2014 06:57P